Published in J Exp Med on January 01, 1996
Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med (1998) 3.20
Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci (2012) 2.01
Circulating interleukin-6 mediates the febrile response to localised inflammation in rats. J Physiol (2000) 1.75
Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects. J Exp Med (1998) 1.65
Role of interleukin-6 in mortality from and physiologic response to sepsis. Infect Immun (2005) 1.57
A novel lipopolysaccharide-induced transcription factor regulating tumor necrosis factor alpha gene expression: molecular cloning, sequencing, characterization, and chromosomal assignment. Proc Natl Acad Sci U S A (1999) 1.56
Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view. Mediators Inflamm (2013) 1.54
Sympathetic neurons can produce and respond to interleukin 6. Proc Natl Acad Sci U S A (1998) 1.51
A mechanism for the inhibition of fever by a virus. Proc Natl Acad Sci U S A (1996) 1.39
Elevated temperature after hypoxic-ischemic encephalopathy: risk factor for adverse outcomes. Pediatrics (2008) 1.39
Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice. Am J Pathol (1997) 1.23
Neither interleukin-6 nor inducible nitric oxide synthase is required for clearance of Chlamydia trachomatis from the murine genital tract epithelium. Infect Immun (1998) 1.23
Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice. J Neuroinflammation (2012) 1.20
Interleukin-6 and rheumatic diseases. Arthritis Res Ther (2006) 1.14
Fever and the thermal regulation of immunity: the immune system feels the heat. Nat Rev Immunol (2015) 1.09
Effects of i.c.v. administration of interleukin-1 on sleep and body temperature of interleukin-6-deficient mice. Neuroscience (2008) 1.03
Evaluation of the in vitro pyrogen test system based on proinflammatory cytokine release from human monocytes: comparison with a human whole blood culture test system and with the rabbit pyrogen test. Clin Diagn Lab Immunol (2002) 1.03
Central and peripheral neuroimmune responses: hyporesponsiveness during pregnancy. J Physiol (2007) 1.02
Exacerbation of CNS inflammation and neurodegeneration by systemic LPS treatment is independent of circulating IL-1β and IL-6. J Neuroinflammation (2011) 1.01
Modelling dynamics of the type I interferon response to in vitro viral infection. J R Soc Interface (2006) 0.99
Effect of Cholecalciferol Supplementation on Vitamin D Status and Cathelicidin Levels in Sepsis: A Randomized, Placebo-Controlled Trial. Crit Care Med (2015) 0.99
Vagal afferents modulate cytokine-mediated respiratory control at the neonatal medulla oblongata. Respir Physiol Neurobiol (2011) 0.97
Satb1 ablation alters temporal expression of immediate early genes and reduces dendritic spine density during postnatal brain development. Mol Cell Biol (2011) 0.96
Tissue-specific opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis. Proc Natl Acad Sci U S A (2012) 0.95
Regulation of a lymphocyte-endothelial-IL-6 trans-signaling axis by fever-range thermal stress: hot spot of immune surveillance. Cytokine (2007) 0.94
Circulating leptin mediates lipopolysaccharide-induced anorexia and fever in rats. J Physiol (2004) 0.94
Hyperresponsive febrile reactions to interleukin (IL) 1alpha and IL-1beta, and altered brain cytokine mRNA and serum cytokine levels, in IL-1beta-deficient mice. Proc Natl Acad Sci U S A (1997) 0.94
Peripheral inflammation is associated with remote global gene expression changes in the brain. J Neuroinflammation (2014) 0.91
Treatment of refractory adult-onset Still's disease with tocilizumab: report of two cases and review of the literature. Rheumatol Int (2011) 0.89
ATF3 Protects against LPS-Induced Inflammation in Mice via Inhibiting HMGB1 Expression. Evid Based Complement Alternat Med (2013) 0.87
Immune-to-brain signaling and central prostaglandin E2 synthesis in fasted rats with altered lipopolysaccharide-induced fever. Am J Physiol Regul Integr Comp Physiol (2008) 0.85
Endogenous interleukin-10 is required for the defervescence of fever evoked by local lipopolysaccharide-induced and Staphylococcus aureus-induced inflammation in rats. J Physiol (2003) 0.85
A variant near the interleukin-6 gene is associated with fat mass in Caucasian men. Int J Obes (Lond) (2010) 0.84
Temporal phenotypic features distinguish polarized macrophages in vitro. Autoimmunity (2015) 0.82
A crucial role for IL-6 in the CNS of rats during fever induced by the injection of live E. coli. Med Microbiol Immunol (2011) 0.80
Nuclear translocation of the transcription factor STAT3 in the guinea pig brain during systemic or localized inflammation. J Physiol (2004) 0.79
Febrile response induced by cecal ligation and puncture (CLP) in rats: involvement of prostaglandin E2 and cytokines. Med Microbiol Immunol (2011) 0.78
Clinical chorioamnionitis at term V: umbilical cord plasma cytokine profile in the context of a systemic maternal inflammatory response. J Perinat Med (2016) 0.78
Anti-IL-6 neutralizing antibody modulates blood-brain barrier function in the ovine fetus. FASEB J (2015) 0.78
New aspects in fenestrated capillary and tissue dynamics in the sensory circumventricular organs of adult brains. Front Neurosci (2015) 0.78
Clinical chorioamnionitis at term IV: the maternal plasma cytokine profile. J Perinat Med (2016) 0.77
LPS alters pattern of sickness behavior but does not affect glutathione level in aged male rats. Biogerontology (2016) 0.75
The role of IL-6 in host defence against infections: immunobiology and clinical implications. Nat Rev Rheumatol (2017) 0.75
Temporal profile of cerebrospinal fluid, plasma, and brain interleukin-6 after normothermic fluid-percussion brain injury: effect of secondary hypoxia. Ther Hypothermia Temp Manag (2012) 0.75
Effect of Physical Exercise on the Febrigenic Signaling is Modulated by Preoptic Hydrogen Sulfide Production. PLoS One (2017) 0.75
Levels of interleukin-1 beta can predict response to tocilizumab therapy in rheumatoid arthritis: the PETITE (predictors of effectiveness of tocilizumab therapy) study. Rheumatol Int (2015) 0.75
Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature (1994) 8.85
Interleukin-6: an overview. Annu Rev Immunol (1990) 7.48
Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol Chemother (1957) 6.28
Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci U S A (1986) 5.60
Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J (1994) 3.60
The neurologic basis of fever. N Engl J Med (1994) 3.38
Fever: role of pyrogens and cryogens. Physiol Rev (1991) 3.13
Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol (1993) 3.03
Defective inflammatory response in interleukin 6-deficient mice. J Exp Med (1994) 2.92
Constitutive and interleukin-1 (IL-1)-inducible factors interact with the IL-1-responsive element in the IL-6 gene. Mol Cell Biol (1990) 2.41
Endotoxin, tumor necrosis factor-alpha and interleukin 1 induce interleukin 6 production in vivo. Clin Immunol Immunopathol (1989) 1.76
Cytokine receptors and signal transduction. FASEB J (1992) 1.55
Transcription factors NF-IL6 and CREB recognize a common essential site in the human prointerleukin 1 beta gene. Mol Cell Biol (1994) 1.36
Lipopolysaccharide induces fever and depresses locomotor activity in unrestrained mice. Am J Physiol (1994) 1.33
Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci Lett (1994) 1.32
Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Eur J Neurosci (1993) 1.31
Reconstitution of the response to leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in hepatoma cells. J Biol Chem (1993) 1.30
Development of a human interleukin-6 receptor antagonist. J Biol Chem (1994) 1.25
Role of interleukin 6 in fever in rats. Am J Physiol (1990) 1.22
Interleukin-1. Adv Pharmacol (1994) 1.19
Induction of tumor necrosis factor-alpha mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6. Brain Res (1993) 1.18
Single-step purification and structural characterization of human interleukin-6 produced in Escherichia coli from a T7 RNA polymerase expression vector. Eur J Biochem (1991) 1.18
Roles of interleukin 1 beta and tumor necrosis factor in lipopolysaccharide fever in rats. Am J Physiol (1990) 1.16
Differential induction of the interleukin-6 gene by tumor necrosis factor and interleukin-1. J Biol Chem (1994) 1.14
Immunoreactive interleukin-1 beta localization in the rat forebrain. Brain Res (1990) 1.10
In vivo evidence that the rise in plasma IL 6 following injection of a fever-inducing dose of LPS is mediated by IL 1 beta. Cytokine (1990) 1.07
Interleukin-6 is a centrally acting endogenous pyrogen in the rat. Can J Physiol Pharmacol (1991) 1.03
Interleukin-6 as an endogenous pyrogen: induction of prostaglandin E2 in brain but not in peripheral blood mononuclear cells. Brain Res (1991) 1.02
Response of interleukin-6-deficient mice to tumor necrosis factor-induced metabolic changes and lethality. Eur J Immunol (1994) 0.99
Blood-borne interleukin-1 alpha is transported across the endothelial blood-spinal cord barrier of mice. J Physiol (1994) 0.92
Role of hypothalamic interleukin-6 and tumor necrosis factor-alpha in LPS fever in rat. Am J Physiol (1993) 0.92
Fever produced by intrahypothalamic injection of interleukin-1 and interleukin-6. Cytokine (1991) 0.92
Kinetics and correlation with body temperature of circulating interleukin-6, interleukin-8, tumor necrosis factor alpha and interleukin-1 beta in patients with fever and neutropenia. Infection (1994) 0.85
Differential expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat hypothalamus. Neurosci Lett (1993) 0.84
Ciliary neurotrophic factor is an endogenous pyrogen. Proc Natl Acad Sci U S A (1993) 0.81
Endotoxin-induced release of interleukin-6 from rat medial basal hypothalami. Endocrinology (1990) 0.80
High affinity interleukin-6 binding sites in bovine hypothalamus. Eur J Pharmacol (1991) 0.79
Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science (1996) 6.70
The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr Biol (2000) 4.24
Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity (1997) 4.19
Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci (2003) 3.38
Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med (1998) 3.20
Defective inflammatory response in interleukin 6-deficient mice. J Exp Med (1994) 2.92
Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. J Immunol (1997) 2.86
CCAAT enhancer- binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy. J Clin Invest (1998) 2.74
Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature (2002) 2.71
Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver. Mol Cell Biol (2001) 2.44
Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J Exp Med (1996) 2.41
Ca2+ signaling via the neuronal calcium sensor-1 regulates associative learning and memory in C. elegans. Neuron (2001) 2.36
Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest (1997) 2.11
Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci U S A (2000) 2.08
Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6. EMBO J (1989) 1.98
Phosphorylation of rat serine 105 or mouse threonine 217 in C/EBP beta is required for hepatocyte proliferation induced by TGF alpha. Mol Cell (1999) 1.91
Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus. J Exp Med (1998) 1.85
C/EBPbeta phosphorylation by RSK creates a functional XEXD caspase inhibitory box critical for cell survival. Mol Cell (2001) 1.80
Giant basal cell carcinoma of the thoracic wall: a case report and review of the literature. Br J Plast Surg (2005) 1.80
Site(s) and ionic basis of alpha-autoinhibition and facilitation of "3H'noradrenaline secretion in guinea-pig vas deferens. J Physiol (1981) 1.76
X-ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motif. EMBO J (2001) 1.75
Preparation of metal-chelate complexes and the design of steady-state kinetic experiments involving metal nucleotide complexes. Adv Cyclic Nucleotide Res (1979) 1.71
Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J Exp Med (1999) 1.68
Cargo delivery kinetics of cell-penetrating peptides. Biochim Biophys Acta (2001) 1.64
Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology (1999) 1.64
Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med (2009) 1.58
Constitutive and IL-6-induced nuclear factors that interact with the human C-reactive protein promoter. EMBO J (1990) 1.53
Dermonodular and visceral leishmaniasis due to Leishmania infantum with a new isoenzyme pattern: report of a case involving a patient with AIDS. Clin Infect Dis (1996) 1.47
Role of STAT3 and PI 3-kinase/Akt in mediating the survival actions of cytokines on sensory neurons. Mol Cell Neurosci (2001) 1.45
Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat Biotechnol (1998) 1.44
Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity. Cytokine (2008) 1.43
Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine. Mol Psychiatry (2006) 1.42
Early outcome of liver transplantation performed with organs procured from brain death donors with transient or sustained cardio-circulatory collapse. Minerva Anestesiol (2014) 1.40
Identification of STAT3 as a specific substrate of breast tumor kinase. Oncogene (2006) 1.40
The induction of cyclooxygenase-2 mRNA in macrophages is biphasic and requires both CCAAT enhancer-binding protein beta (C/EBP beta ) and C/EBP delta transcription factors. J Biol Chem (2001) 1.39
Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signalling. EMBO J (1995) 1.39
Homophilic interaction of junctional adhesion molecule. J Biol Chem (2000) 1.37
Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: histochemical, autoradiographic, in vivo, and in vitro studies. Proc Natl Acad Sci U S A (1987) 1.37
Role of IL-6 in cytokine-induced sickness behavior: a study with IL-6 deficient mice. Physiol Behav (2000) 1.32
Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector. Proc Natl Acad Sci U S A (1999) 1.32
VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions. Exp Cell Res (2001) 1.29
Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice. Am J Pathol (1997) 1.28
Circadian regulation of diverse gene products revealed by mRNA expression profiling of synchronized fibroblasts. J Biol Chem (2001) 1.26
STAT3 can serve as a hit in the process of malignant transformation of primary cells. Cell Death Differ (2012) 1.24
Galanin reduces release of endogenous excitatory amino acids in the rat hippocampus. Eur J Pharmacol (1993) 1.24
Sickness behavior in mice deficient in interleukin-6 during turpentine abscess and influenza pneumonitis. Am J Physiol (1997) 1.23
Hypoglycemia and impaired hepatic glucose production in mice with a deletion of the C/EBPbeta gene. J Clin Invest (1999) 1.22
Galanin induces a hyperpolarization of norepinephrine-containing locus coeruleus neurons in the brainstem slice. Neuroscience (1995) 1.18
Induction of tumor necrosis factor-alpha mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6. Brain Res (1993) 1.18
C/EBP regulates hepatic transcription of 11beta -hydroxysteroid dehydrogenase type 1. A novel mechanism for cross-talk between the C/EBP and glucocorticoid signaling pathways. J Biol Chem (2000) 1.17
Voltage-sensitive calcium channels regulate guanosine 3',5'-cyclic monophosphate levels in neuroblastoma cells. Proc Natl Acad Sci U S A (1978) 1.17
Uncoupling proteins-2 and 3 influence obesity and inflammation in transgenic mice. Int J Obes Relat Metab Disord (2003) 1.15
Cellular translocation of proteins by transportan. FASEB J (2001) 1.15
Mice with a deletion in the gene for CCAAT/enhancer-binding protein beta have an attenuated response to cAMP and impaired carbohydrate metabolism. J Biol Chem (2001) 1.15
Galanin, galanin receptors and drug targets. Cell Mol Life Sci (2008) 1.14
Interleukin-1beta induces hyperpolarization and modulates synaptic inhibition in preoptic and anterior hypothalamic neurons. Neuroscience (2006) 1.13
Coexistence of peptides with classical neurotransmitters. Experientia (1987) 1.13
Role of xanthine oxidase and reactive oxygen intermediates in LPS- and TNF-induced pulmonary edema. J Lab Clin Med (1994) 1.12
Characteristics of the adeno-associated virus preintegration site in human chromosome 19: open chromatin conformation and transcription-competent environment. J Virol (2000) 1.12
Genotyping Encephalitozoon hellem isolates by analysis of the polar tube protein gene. J Clin Microbiol (2001) 1.12
Suppressed kindling epileptogenesis in mice with ectopic overexpression of galanin. Proc Natl Acad Sci U S A (2001) 1.11
The effects of atropine on [3H]acetylcholine secretion from guinea-pig myenteric plexus evoked electrically or by high potassium. J Physiol (1982) 1.11
Patterns of seizures, hippocampal injury and neurogenesis in three models of status epilepticus in galanin receptor type 1 (GalR1) knockout mice. Neuroscience (2004) 1.11
N-acetylcysteine and glutathione as inhibitors of tumor necrosis factor production. Cell Immunol (1992) 1.10
Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activation. EMBO J (1994) 1.10
Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBP beta-deficient mice. J Exp Med (1996) 1.08
Electrophysiological properties and thermosensitivity of mouse preoptic and anterior hypothalamic neurons in culture. Neuroscience (2005) 1.07
Lipofection of purified adeno-associated virus Rep68 protein: toward a chromosome-targeting nonviral particle. J Virol (1998) 1.07
Muscarinic autoreceptor regulates acetylcholine release in rat hippocampus: in vitro evidence. Acta Physiol Scand (1980) 1.06
The transcription factor C/EBPbeta is essential for inducible expression of the cox-2 gene in macrophages but not in fibroblasts. J Biol Chem (2001) 1.06
Impaired Stat3 activation following localized inflammatory stimulus in IL-6-deficient mice. Cytokine (1998) 1.06
Galanin-mediated control of pain: enhanced role after nerve injury. Proc Natl Acad Sci U S A (1992) 1.06
Impaired generation of bone marrow B lymphocytes in mice deficient in C/EBPbeta. Blood (1997) 1.06
Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2(s)-M2 tetracycline transactivator and repressor system. Gene Ther (2002) 1.05
Development of animal models for adeno-associated virus site-specific integration. J Virol (1999) 1.04
Cytokine regulation of neuronal survival. J Neurochem (1992) 1.03
Role of the isoforms of CCAAT/enhancer-binding protein in the initiation of phosphoenolpyruvate carboxykinase (GTP) gene transcription at birth. J Biol Chem (1997) 1.03
The primary structure of human hemopexin deduced from cDNA sequence: evidence for internal, repeating homology. Nucleic Acids Res (1985) 1.03
Autoradiographic quantitation and anatomical mapping of 125I-galanin binding sites in the rat central nervous system. J Chem Neuroanat (1989) 1.03
In vivo hepatocyte proliferation is inducible through a TNF and IL-6-independent pathway. Oncogene (1998) 1.02
C/EBPbeta is required for the late phases of acute phase genes induction in the liver and for tumour necrosis factor-alpha, but not Interleukin-6, regulation. Cell Death Differ (1996) 1.02
Microsporidian spore wall: ultrastructural findings on Encephalitozoon hellem exospore. J Eukaryot Microbiol (1996) 1.01
IL-6 is essential in TNF-alpha-induced fever. Am J Physiol (1998) 1.01
Evidence for an inhibitory effect of the peptide galanin on dopamine release from the rat median eminence. Neurosci Lett (1987) 1.01
N-terminal galanin-(1-16) fragment is an agonist at the hippocampal galanin receptor. Proc Natl Acad Sci U S A (1989) 1.00
Delineation of the proinflammatory cytokine cascade in fever induction. Ann N Y Acad Sci (1998) 0.99
Interleukin-6 (IL-6) antagonism by soluble IL-6 receptor alpha mutated in the predicted gp130-binding interface. J Biol Chem (1995) 0.99
Fever: links with an ancient receptor. Curr Biol (1999) 0.99
Linear and cyclic N-terminal galanin fragments and analogs as ligands at the hypothalamic galanin receptor. Int J Pept Protein Res (1991) 0.98
Human interleukin-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cells. Blood (1996) 0.98
The transcription factor CCAAT/enhancer-binding protein beta regulates gluconeogenesis and phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes. J Biol Chem (1999) 0.98
Nociceptive responses in interleukin-6-deficient mice to peripheral inflammation and peripheral nerve section. Cytokine (1997) 0.98
Treatment of reticulate acropigmentation of Kitamura with azelaic acid. J Am Acad Dermatol (1993) 0.98
Cutaneous leishmaniasis in acquired immunodeficiency syndrome. Trans R Soc Trop Med Hyg (1990) 0.98
Fluorescence correlation spectroscopy detects galanin receptor diversity on insulinoma cells. Biochemistry (2001) 0.98